Page URL: https://www.bionews.org.uk/0657
CONTENTS Issue #657
COMMENT
The Daily Mail has got Altrui and egg donation wrong
BioNews survey 2012: The results
NEWS DIGEST
REVIEWS
TV Review: 4thought - Should We Be Allowed to Design Babies?
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 


Visit the BioNews website at www.bionews.org.uk where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

The Daily Mail has got Altrui and egg donation wrong
21 May 2012 - by Alison Bagshawe
A recent article in the Daily Mail about Altrui's information campaign towards students at Cambridge University typifies popular press reporting at its worst and exemplifies some recurring myths about egg donation... [Read More]
BioNews survey 2012: The results
21 May 2012 - by Dr Jess Buxton
A huge thank-you to the 700 readers who took the time to complete our survey earlier this year. As with previous surveys, the results will be invaluable for the future development of BioNews, to ensure it continues to meet the needs of our readers... [Read More]
Probiotic yoghurt makes male mice sexier
21 May 2012 - by Jessica Ware
For mice at least, probiotic yoghurt could be the secret behind staying slim and 'sexy'. Scientists at the Massachusetts Institute of Technology in the US came to this conclusion after a study to evaluate the effect of yoghurt on age-related weight gain... [Read More]
Canadian regulators grant world's first approval for a stem cell drug
21 May 2012 - by Victoria Kay
The world's first stem cell drug has been approved by Canadian authorities. US biotech company, Osiris Therapeutics, has been given the go-ahead to market its drug, Prochymal, for the treatment of graft-versus-host-disease (GvHD) in children who fail to respond to steroids.... [Read More]
Private equity firm invests in successful London IVF clinic
21 May 2012 - by Ruth Retassie
A London-based IVF clinic has received an investment from a private equity firm to open more fertility clinics in the UK and abroad.... [Read More]
Rare genetic variants unexpectedly common in humans
21 May 2012 - by Dr Linda Wijlaars
Rare genetic variants - those carried by fewer than five in 1,000 people - are much more common than previously thought, according to two studies published in Science... [Read More]
MRSA spread from city to regional hospitals tracked with genetic tags
21 May 2012 - by James Brooks
The emergence and spread of MRSA in the UK has been tracked thanks to genetic analysis of samples taken from infected patients over a 53-year period. The study, published in the journal PNAS, suggests that hospitals in large cities act as breeding grounds for new, increasingly resistant MRSA variants... [Read More]
Genetics of breast cancer progression mapped
21 May 2012 - by Dr Rebecca Hill
The genetic landscape of breast cancer is much more complicated than previously hoped, according to the authors of two analyses of multiple tumour genomes... [Read More]
Chemicals in environment can damage fertility - in male sheep
21 May 2012 - by Dr Victoria Burchell
Exposure to low levels of environmental toxins may reduce male sperm counts, research in sheep suggests... [Read More]
Senior IVF doctor declaims 'serious health risk' of ovarian stimulation
21 May 2012 - by Dr Greg Ball
A senior IVF doctor has voiced concerns over health risks to women in IVF treatments that are commonly practiced by UK clinics... [Read More]
Sir Alasdair Breckenridge appointed Chair of Emerging Science and Bioethics Advisory Committee
21 May 2012 - by Antony Starza-Allen
Sir Alasdair Breckenridge has been appointed as Chair of the Government's new advisory body on the implications of developments in bioscience, the Emerging Science and Bioethics Advisory Committee (ESBAC).... [Read More]
TV Review: 4thought - Should We Be Allowed to Design Babies?
21 May 2012 - by Daniel Malynn
These seven short films provide little more than a string of provocative quotations, which do little in themselves to foster a good debate of a complex issue. While all the speakers' opinions and experiences provide a range of views on the issues raised by genetic screening, there is a clear lack of consistency in some of the arguments. The question posed in the title loosely runs throughout but the films lack collective coherency with little linkage between them.... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at snorcross@progress.org.uk

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX